anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

216,301-216,360 of 319,975

filter-aware
09
Pathward Financial | Investor Presentation Deck | 23 slidesPathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · Financials1 hit
10
Includes a legend for extraordinary items and a disclaimer regarding non-GAAP adjustments for FY 2022.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
Peer group defined as commercial insured banks with assets between $3-10 billion.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
12
The slide uses a Venn-like circular layout to present two key capital return metrics alongside qualitative operational targets.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
13
The slide uses a grid of 8 metric cards, each with an icon, a headline number, and a descriptive sub-text.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
14
The diagram uses a hub-and-spoke model to visualize the central position of Pathward in the financial ecosystem.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
15
The slide uses a four-column layout to categorize business lines.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
16
The chart highlights the acquisition of Crestmark in 2018.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
17
The slide uses a horizontal arrow to imply a unified, integrated approach across these four domains.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
18
Pathward Financial | Investor Presentation Deck | 23 slidesPathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
19
Standard financial disclosure slide for non-GAAP metrics.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
20
The slide uses a hierarchical tree structure to represent the balance sheet components.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
21
The slide uses two distinct waterfall diagrams to explain how Pathward secures its position in different financial products.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
22
Pathward Financial | Investor Presentation Deck | 23 slidesPathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
23
Two-column reference glossary with bolded term headings and short paragraph definitions; no charts or imagery beyond the page footer and Pathward logo.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
01
Slide 1
RayzeBio | IPO Presentation Deck | 41 slidesRayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
02
RayzeBio | IPO Presentation Deck | 41 slidesRayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
03
This is a standard IPO/follow-on offering summary table.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
04
The slide uses a structured table format to present key company metrics and status.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
05
RayzeBio | IPO Presentation Deck | 41 slidesRayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
06
The slide uses a Gantt-style visualization for drug development stages.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
07
Uses a visual metaphor of 'Outside in' vs 'Precise from within' to contrast the two treatment modalities.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
08
The slide uses a simple comparison framework to highlight clinical benefits.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
09
The slide uses a comparison framework to justify the use of alpha-emitting isotopes in targeted radiotherapy.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · Problem1 hit
10
The slide uses a chronological progression of therapeutic classes (Targeted, Immuno-oncology, ADCs, Cell Therapy) leading to RPT.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
11
The slide uses a comparison table to validate the market potential of the radiopharmaceutical space by highlighting a competitor's success.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
12
The slide uses a process flow diagram to show the standard of care progression for two types of NETs.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
13
The slide uses a Kaplan-Meier curve to contrast Lutathera against a control group, highlighting the clinical limitation of the current standard of care.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The chart compares median progression vs median survival in months across three patient cohorts (Pancreatic, GI, Overall).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
15
The slide uses a chemical structure comparison to illustrate the similarity in binder/chelator while highlighting the difference in radioisotope.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · Solution1 hit
16
The slide uses a process-oriented layout to show the transition between trial phases.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
17
The table specifically highlights that there were zero treatment-related serious adverse events (SAE) and zero discontinuations.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
18
Waterfall plot displays individual patient responses; benchmarking table compares ORR against historical standards.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
19
The chart tracks patient follow-up in weeks, with markers indicating dose, dose reduction, and clinical response (Partial Response, Progressive Disease, Stable Disease).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
20
RayzeBio | IPO Presentation Deck | 41 slidesRayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
21
The slide uses a standard clinical trial flow diagram (Population -> Treatment -> Endpoints -> Crossover).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Hypothesis Test1 hit
22
The slide uses a three-column layout to break down the market opportunity into patient population, pricing, and launch dynamics.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · Market Sizing1 hit
23
The slide highlights that 47% of SCLC samples show some level of SSTR2 expression, with 27% showing high expression.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
24
Includes a visual case study with PET scan images showing tumor reduction.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
25
The chart shows tumor growth over 57 days across four treatment groups, with the combination therapy (green line) demonstrating the most effective tumor suppression.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
26
The slide outlines a clinical trial protocol for a combination therapy involving RYZ101, chemotherapy, and PD-L1 inhibitors.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
27
Includes PET scan imagery and a pharmacokinetic tumor uptake graph comparing RAYZ-SSTR to DOTATATE.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
28
CMC stands for Chemistry, Manufacturing, and Controls. The slide highlights infrastructure investment and current CDMO reliance.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
29
The workflow includes a feedback loop from in vivo screening back to binder discovery.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
30
The slide uses a staircase-style diagram to represent progression in clinical relevance of data.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
31
Includes IHC staining images and a waterfall plot showing tumor shrinkage.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
32
The slide demonstrates the efficacy and specificity of the drug candidate in a preclinical model.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
33
Comparison of 225Ac vs 177Lu efficacy at significantly different dose levels.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
34
Includes clinical imaging examples for two patients.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
35
The slide uses a longitudinal imaging sequence to demonstrate drug efficacy/retention.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
36
The slide uses a process flow diagram to illustrate the regulatory and clinical milestones.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
37
The slide lists 24 investor logos/names.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
38
RayzeBio | IPO Presentation Deck | 41 slidesRayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
39
Includes 88 FTEs count and board member list.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · Team1 hit
40
The slide uses a vertical process flow to illustrate vertical integration.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
41
This is a closing or transition slide featuring the company logo and mission statement.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
01
Slide 1
Rent The Runway | Results Presentation Deck | 32 slidesRent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations 1 hit
02
Rent The Runway | Results Presentation Deck | 32 slidesRent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations 1 hit
03
The slide uses a 2x2 grid layout to present four key financial metrics over a four-year period.Rent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations 1 hit
04
Rent The Runway | Results Presentation Deck | 32 slidesRent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations 1 hit